life scienc diagnost tool
impress capit deploy capac head
buy rais pt recap
rais pt reiter buy cap
solid note beat guidanc consensu expect
top bottom line encourag wat solid growth
momentum head specif continu strong demand
china improv condit north america india
biopharma end market global notabl recur revenu
stand-alone lc instrument sale consist strong throughout
mass spectrometri order growth exceed revenu growth
well look ahead ep guidanc particularli noteworthi
view exceed consensu expect display wat
signific capit deploy capac benefit tax
reform new billion share repurchas program also announc
guid billion repurchas addit
water divis instrument side compani posit launch
meaning new product throughout bioaccord lc-m system
biopharma applic introduc januari drive
instrument sale growth next sever year view
revis pt repres premium price-to-earnings basi compar peer group
large-cap lst compani think warrant given wat ep
leverag capit deploy industry-lead margin profil
vs peer group potenti acceler top line
growth host analyst investor day februari
new york citi
model updat revenu ep est
y/i vs prior y/i vs prior
revenu ep est y/i
valuat pt base price-to-earnings
btig estim compani document million except per share amount
pleas read import disclosur analyst certif appear appendix
exhibit varianc million except per share data
exhibit segment detail growth constant currenc
strength core lc
lc-m sold
driven ms
flat driven ms
flat strength
strength
year
strength lc
driven qa/qc
full
actualguidancestreet estimate btig chang cc gross incom oper margin rate incom chang incl
exhibit end market color geographi growth constant currenc
 growth
strength ta
pick spend
mid-siz
custom
cautiou
earlier year
instrument
solid growth
pharma
weak
growth
driven soft
biomed
research well
slower
growth canada
latin america
rico strong
industri
mic strong
fy
fy
 growth
spend
 sale flat
strength pharma
off-set soft
clinic
applic
strong growth
canada latin
head
end
weak clinic
growth
soft
industri
applic
strength central
southern
eastern europ
larg due macro
industri
ent drag
region
saw strength
growth across
region
pharma
strength small
applic
demand
revenu
larg grow
instal base
across key
grew
disrupt
due new gst
india grew hsd
steadi growth
japan full
china sale
weak india
japan
lsd in-lin
china
driven pharma
food materi
growth expect
china grew
strong growth
pharma food
market off-set
soft ta
modest growth
growth
fy doubl digit
growth china
growth china
led strong growth
pharma
strong growth
korea japan
india flat y/i
sale india
see growth
opportun
area
exhibit end market color custom type growth constant currenc
strong demand
growth
fy
 doubl
digit growth
rebound india
sale
doubl digit
growth china
msd
growth china
slight declin
growth china
due slower
releas larg
improv
continu
trend
growth china
improv
us
soft europ
india
modest declin
declin sale
strength
food market
demand lc
pocket
weak
europ india
sale
research
year
growth
fy
led strength
food
strength
growth across
weak
research
off-set
improv
research
strong growth
asia
off-set softer
demand europ
weak
research off-set
strength
research
growth
fy
strong growth
off-set softer
growth europ
america
strength
partial off-set
weak
declin
prior year
notabl mass
spec sale
chemic food
custom due
part territori
realign
ta continu
seen last year
industri china
bit lumpi
strong growth
china driven
across major
weak
academ
biomed
custom
headwind
continu strength china improv condit
headwind
india us europ
increment contribut new product
continu growth recur revenu
consist histor trend
target growth rate sale growth
higher y/i use balanc sheet work toward
near-term capit structur net debt ebitda
moder increas expens
increas due time discret item y/i
assum share repurchas million
billion full year
includ fx headwind
includ fx headwind
fiscal year end dec million except per share profit develop intang incom expens oper incom incom incom analysiscost margin gener administr develop margin tax margin growthnet margin bpsoper incom margin bpsnet incom compani report btig estim
btig cover compani mention report
appendix analyst certif import disclosur
